Aapharmasyn LLC

Ann Arbor, MI Doing business as AAP Part of Aprc Corp

UEI
YUFFPW8FVKX2
CAGE
6NX94
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
  • Aprc Corp Parent G7MZE43E6Q68
    • Aapharmasyn LLC YUFFPW8FVKX2
SAM.gov registration date
Physical address
3915 Research Park Dr #1A, Ann Arbor, MI 48108, USA
Website
aapharmasyn.com
Founded
2006
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Materials
  2. Chemicals
  3. Commodity Chemicals
SIC code
73 Business Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Aapharmasyn LLC's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Interventional agents chemistry services Contract · 75N93026F00002 National Institute of Allergy and Infectious Diseases $580,843
To award base IDIQ contract for interventional agents chemistry services under task area b. Contract · 75N93026F00001 National Institute of Allergy and Infectious Diseases $147,236
Experimental therapeutics medicinal chem Contract · W81XWH19F0041 Medical Command $17,958
Experimental therapeutics medicinal chem Contract · W81XWH18F0124 Medical Command $82,000
Experimental therapeutics medicinal chem Contract · W81XWH18F0099 Medical Command $77,780

About Aapharmasyn LLC

Written by GovTribe AI ·

Aapharmasyn LLC, doing business as AAP, is a small disadvantaged business based in Ann Arbor, Michigan that provides experimental therapeutics medicinal chemistry and interventional agents chemistry research and development services to federal agencies as a prime contractor exclusively. The firm operates as a child entity of Aprc Corp and competes full-and-open rather than under set-aside vehicles.

AAP's federal footprint centers on three customer agencies, with the National Institute of Allergy and Infectious Diseases (NIAID) anchoring 86% of combined potential value. In September 2025, NIAID awarded AAP a single-award indefinite-delivery contract with a $50 million ceiling through September 2032 for interventional agents chemistry agents, under which two delivery orders have been issued to date: a $147,236 firm-fixed-price order under Task Area B (completion July 29, 2026) and a $1,127,656 cost-plus-fixed-fee order (completion March 23, 2027). Both orders are performed at the Ann Arbor location. The Army Medical Command has placed seven awards totaling $7.7 million combined potential value across two primary vehicles (the Army's W81XWH12D0028 IDIQ and an Experimental Therapeutics Medicinal Chemistry vehicle), while the Defense Health Agency has placed two awards totaling $160 thousand. AAP works exclusively in a prime role across its twelve recorded awards spanning 2012 to June 2026.

The vendor's capability portfolio aligns with biotechnology and nanotechnology R&D, with awards coded primarily to Research and Development in Biotechnology (5 awards) and Research and Development in Nanotechnology (4 awards). Only $1.3 million in combined potential value faces recompete in the next twenty-four months; the bulk of exposure sits under the NIAID IDIQ's seven-year term. Total obligated dollars across all awards stand at $1.1 million against $59.1 million in combined potential value, reflecting the recent character of the IDIQ award and its delivery-order execution model.

Contract vehicles

Aapharmasyn LLC holds a place on 1 federal contract vehicle. Active vehicles first.

SBA capabilities narrative

From the vendor's SBA profile

We specializes in custom synthesis and contract research. We offer our customers a broad range of services which include first-time synthesis of complex and commercially not available compounds, optimization of synthetic routes and supply of exclusive chemicals amongst others. Our team tackled multi-step syntheses of complex molecules, including chemical intermediates, drug metabolites, process impurities, degradants, reference compounds, preclinical drug candidates, and other organic molecules.

Quick answers

What is Aapharmasyn LLC's UEI?

Aapharmasyn LLC's Unique Entity ID (UEI) in SAM.gov is YUFFPW8FVKX2.

What is Aapharmasyn LLC's CAGE code?

Aapharmasyn LLC's CAGE code is 6NX94.

What is Aapharmasyn LLC's primary NAICS code?

Aapharmasyn LLC's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Where is Aapharmasyn LLC located?

Aapharmasyn LLC's physical address in SAM.gov is 3915 Research Park Dr #1A, Ann Arbor, MI 48108, USA.

Is Aapharmasyn LLC registered in SAM.gov?

Yes. Aapharmasyn LLC's SAM.gov registration is active through July 27, 2027.

Who is Aapharmasyn LLC's parent company?

Aapharmasyn LLC is part of Aprc Corp.

Which contract vehicles does Aapharmasyn LLC hold?

Aapharmasyn LLC holds a place on 1 federal contract vehicle: Experimental Therapeutics Medicinal Chemistry.

What is Aapharmasyn LLC's most recent federal award?

Aapharmasyn LLC's most recent federal contract award is Interventional agents chemistry services (75N93026F00002), from National Institute of Allergy and Infectious Diseases, on June 24, 2026.

On GovTribe

See Aapharmasyn LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login